Article

Bausch & Lomb raises awareness for breast cancer with contact lens case

In an effort to raise awareness for breast cancer, Bausch & Lomb will be giving away 40 limited-edition pink crystallized Swarovski Elements contact lens cases.

Rochester, NY-In an effort to raise awareness for breast cancer, Bausch & Lomb will be giving away 40 limited-edition pink crystallized Swarovski Elements contact lens cases exclusively online at www.ReNuCares.com during October Breast Cancer Awareness Month.

"Crystallized Swarovski Elements is known for its legendary crystal artistry. It has transformed a functional contact lens case into a unique work of art that contest winners will be able to use and admire at the same time," said Lisa Van DeMark, vice president, marketing, U.S. Lens Care.

"We wanted to create something memorable and elegant for Breast Cancer Awareness Month this October. We're proud to partner with Bausch & Lomb in recognition and support of Susan G. Komen for the Cure," says Stephan Toljan, vice president of marketing for Crystallized.

The contest, launched Sept. 2, will end Oct. 31. Visitors who download a coupon for the company's contact lens solution (ReNu MultiPlus) will be entered automatically for a chance to win one of the limited-edition contact lens cases. No purchase is necessary to be entered to win. Bausch & Lomb will notify winners by Nov. 15.

Bausch & Lomb will also donate $1 to Susan G. Komen for the Cure for every coupon that is redeemed at a retail store.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.